PubMed · 7979424
[Treatment of prostatic carcinoma with UFT and leucovorin--basic study using SRCA].
Abstract
Combination effect of UFT and leucovorin against the rat prostatic carcinoma (R-3327) was evaluated by the subrenal capsular assay (SRCA) using nude mice. Anticancer effect of UFT was augmented by co-administration of both low and high dose leucovorin. These results suggest a clinical usefulness of UFT administration with leucovorin for the patients with hormonally refractory advanced prostatic carcinoma.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
K Uchida, T Hayashi, T Shiga, K Hattori, Y Nishijima, S Kasaya, T Shimazui, H Akaza, K Koiso, R Nemoto. 1994. [Treatment of prostatic carcinoma with UFT and leucovorin--basic study using SRCA].. https://pubmed.ncbi.nlm.nih.gov/7979424/
Cite the original work for its findings. Save a collection to share your selection of sources.